Early Targeted Combination Treatment With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs and Long‐Term Outcomes in Rheumatoid Arthritis: Ten‐Year Follow‐Up Results of a Randomized Clinical Trial-Reference-Cited by-同舟云学术

Early Targeted Combination Treatment With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs and Long‐Term Outcomes in Rheumatoid Arthritis: Ten‐Year Follow‐Up Results of a Randomized Clinical Trial

Published:2019-10-29 Issue:11 Volume:71 Page:1450-1458
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Rantalaiho Vappu¹,Sandström Tia²,Koski Juhani³,Hannonen Pekka⁴,Möttönen Timo⁵,Kaipiainen‐Seppänen Oili⁶,Yli‐Kerttula Timo⁷,Kauppi Markku J.⁸,Uutela Toini⁹,Malmi Timo¹⁰,Julkunen Heikki¹¹,Laasonen Leena¹¹,Kautiainen Hannu¹²,Leirisalo‐Repo Marjatta²,

Affiliation:

1. Tampere University Hospital Tampere Finland

2. University of Helsinki and Helsinki University Hospital Helsinki Finland

3. Mikkeli Central Hospital Mikkeli Finland

4. Jyväskylä Central Hospital Jyväskylä Finland

5. Turku University Central Hospital and University of Turku Turku Finland

6. Kuopio University Hospital Kuopio Finland

7. Rauma Regional Hospital Rauma Finland

8. Päijät‐Häme Central Hospital, Lahti, and Tampere University Tampere Finland

9. Lapland Central Hospital Rovaniemi Finland

10. Seinäjoki Central Hospital Seinäjoki Finland

11. Helsinki University Central Hospital Helsinki Finland

12. Kuopio University Hospital, Kuopio, and Folkhälsan Research Center Helsinki Finland

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.23782

Reference25 articles.

1. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen JS;Ann Rheum Dis,2010

2. Early remission is a realistic target in a majority of patients with DMARD‐naive rheumatoid arthritis;Rannio T;J Rheumatol,2016

3. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review;Van Nies JA;Ann Rheum Dis,2014

4. Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission;Mäkinen H;Clin Exp Rheumatol,2006

5. The good initial response to therapy with a combination of traditional disease‐modifying antirheumatic drugs is sustained over time: the eleven‐year results of the Finnish Rheumatoid Arthritis Combination Therapy trial;Rantalaiho V;Arthritis Rheum,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and cost-effectiveness of triple therapy in preventing relapse in rheumatoid arthritis: A randomized controlled trial (ESCoRT study);Chinese Medical Journal;2022-09-20

2. A hybrid Grey Wolf Optimization and Particle Swarm Optimization with C4.5 approach for prediction of Rheumatoid Arthritis;Applied Soft Computing;2020-09

3. Treatment strategies are more important than drugs in the management of rheumatoid arthritis;Clinical Rheumatology;2020-02-22

4. Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study;The Journal of Rheumatology;2019-11-15